ArticleEuropean journal of hospital pharmacy : science and practice2022

Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study.

David Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.